Search hospitals > Michigan > Farmington
QUEST Research Institute
Claim this profileFarmington, Michigan 48334
Global Leader in Parkinson's Disease
Global Leader in Alzheimer's Disease
Conducts research for Dementia
Conducts research for Migraine
Conducts research for Cognitive Impairment
111 reported clinical trials
3 medical researchers
Summary
QUEST Research Institute is a medical facility located in Farmington, Michigan. This center is recognized for care of Parkinson's Disease, Alzheimer's Disease, Dementia, Migraine, Cognitive Impairment and other specialties. QUEST Research Institute is involved with conducting 111 clinical trials across 113 conditions. There are 3 research doctors associated with this hospital, such as Aaron Ellenbogen, DO, MPH, Mohammed Ibrahim, MD, and Peter LeWitt.Area of expertise
1Parkinson's Disease
Global LeaderStage II
Stage I
Stage III
2Alzheimer's Disease
Global LeaderTop PIs
Aaron Ellenbogen, DO, MPHQuest Research Institute3 years of reported clinical research
Studies Parkinson's Disease
Studies Alzheimer's Disease
21 reported clinical trials
19 drugs studied
Mohammed Ibrahim, MDQUEST Research Institute7 years of reported clinical research
Studies Lung Cancer
Studies Ovarian Cancer
2 reported clinical trials
3 drugs studied
Peter LeWittQuest Research Institute, LLC2 years of reported clinical research
Studies Parkinson's Disease
Studies Neurodegenerative Diseases
2 reported clinical trials
3 drugs studied
Clinical Trials running at QUEST Research Institute
Parkinson's Disease
Alzheimer's Disease
Cognitive Impairment
Dementia
Memory Loss
Flu
Neurodegenerative Diseases
Healthy Subjects
Polycystic Kidney Disease
Multiple Sclerosis
CREXONT ER
for Parkinson's Disease
The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).
Recruiting3 awards Phase 42 criteria
Bemdaneprocel
for Parkinson's Disease
Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).
Recruiting1 award Phase 33 criteria
CVN424
for Parkinson's Disease
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.
Recruiting1 award Phase 317 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at QUEST Research Institute?
QUEST Research Institute is a medical facility located in Farmington, Michigan. This center is recognized for care of Parkinson's Disease, Alzheimer's Disease, Dementia, Migraine, Cognitive Impairment and other specialties. QUEST Research Institute is involved with conducting 111 clinical trials across 113 conditions. There are 3 research doctors associated with this hospital, such as Aaron Ellenbogen, DO, MPH, Mohammed Ibrahim, MD, and Peter LeWitt.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.